Yasuda S - Search Results

1

Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial.

Saxena A, Ginzler EM, Gibson K, Satirapoj B, Santillán AEZ, Levchenko O, Navarra S, Atsumi T, Yasuda S, Chavez-Perez NN, Arriens C, Parikh SV, Caster DJ, Birardi V, Randhawa S, Lisk L, Huizinga RB, Teng YKO. Saxena A, et al. Among authors: yasuda s. Arthritis Rheumatol. 2024 Jan;76(1):59-67. doi: 10.1002/art.42657. Epub 2023 Sep 15. Arthritis Rheumatol. 2024. PMID: 37466424

2

Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies.

Yasuda S, Tsutsumi A, Atsumi T, Bertolaccini ML, Ichikawa K, Khamashta MA, Hughes GR, Koike T. Yasuda S, et al. J Rheumatol. 2002 Jun;29(6):1192-7. J Rheumatol. 2002. PMID: 12064834

3

Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.

Yasuda S, Atsumi T, Ieko M, Koike T. Yasuda S, et al. Thromb Res. 2004;114(5-6):461-5. doi: 10.1016/j.thromres.2004.07.013. Thromb Res. 2004. PMID: 15507279 Review.

4

Antiprothrombin antibodies--are they worth assaying?

Atsumi T, Amengual O, Yasuda S, Koike T. Atsumi T, et al. Among authors: yasuda s. Thromb Res. 2004;114(5-6):533-8. doi: 10.1016/j.thromres.2004.08.024. Thromb Res. 2004. PMID: 15507288 Review.

5

Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.

Yasuda S, Atsumi T, Matsuura E, Kaihara K, Yamamoto D, Ichikawa K, Koike T. Yasuda S, et al. Arthritis Rheum. 2005 Jan;52(1):212-8. doi: 10.1002/art.20741. Arthritis Rheum. 2005. PMID: 15641049 Free article.

6

Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element.

Fukae J, Amasaki Y, Yamashita Y, Bohgaki T, Yasuda S, Jodo S, Atsumi T, Koike T. Fukae J, et al. Among authors: yasuda s. Arthritis Rheum. 2005 Sep;52(9):2697-707. doi: 10.1002/art.21258. Arthritis Rheum. 2005. PMID: 16142751 Free article.

7

Research around beta 2-glycoprotein I: a major target for antiphospholipid antibodies.

Atsumi T, Amengual O, Yasuda S, Matsuura E, Koike T. Atsumi T, et al. Among authors: yasuda s. Autoimmunity. 2005 Aug;38(5):377-81. doi: 10.1080/08916930500124312. Autoimmunity. 2005. PMID: 16227153 Review.

8

Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway.

Yasuda S, Bohgaki M, Atsumi T, Koike T. Yasuda S, et al. Immunobiology. 2005;210(10):775-80. doi: 10.1016/j.imbio.2005.10.009. Epub 2005 Oct 21. Immunobiology. 2005. PMID: 16325497 Free article. Review.

9

A polymorphism in human platelet antigen 6b and risk of thrombocytopenia in patients with systemic lupus erythematosus.

Amengual O, Atsumi T, Komano Y, Kataoka H, Horita T, Yasuda S, Koike T. Amengual O, et al. Among authors: yasuda s. Arthritis Rheum. 2007 Aug;56(8):2803-5. doi: 10.1002/art.22799. Arthritis Rheum. 2007. PMID: 17665449 Free article. No abstract available.

10

Polymyalgia rheumatica as the manifestation of unclassified aortitis.

Kataoka H, Atsumi T, Hashimoto T, Horita T, Yasuda S, Koike T. Kataoka H, et al. Among authors: yasuda s. Mod Rheumatol. 2008;18(1):105-8. doi: 10.1007/s10165-007-0019-7. Epub 2007 Dec 22. Mod Rheumatol. 2008. PMID: 18157647

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,506 results

Search Page